Spanning External Fixation for the Treatment of Open Joint Injuries in Pediatric Burn Patients

Kelly Carmichael1, Daniel Torres2, Carlos J Jimenez3

  • 1Department of Orthopaedic Surgery and Rehabilitation, University of Texas Medical Branch.

Cureus
|June 21, 2018
PubMed

Insights

Spanning external fixation (SEF) effectively treats pediatric open joint burn injuries, reducing the need for multiple skin grafts. Early SEF application promotes healing and improves outcomes for these challenging cases.

Area of Science:

  • Orthopedic Surgery
  • Pediatric Burn Care
  • Trauma Management

Background:

  • Open joint injuries in pediatric burn patients are complex and challenging to manage.
  • Traditional treatments often involve multiple interventions, including extensive skin grafting.

Observation:

  • A case series reviewed nine pediatric patients with open joint burn injuries treated with spanning external fixators (SEFs).
  • Patients presented with severe burns (average 49.4% TBSA), affecting elbows and knees, with an average age of 8.6 years.
  • SEF placement occurred an average of 7.1 weeks post-burn, following numerous prior skin grafting procedures.

Findings:

  • SEF treatment resulted in a significant reduction in subsequent skin grafting procedures (average 0.6 post-SEF vs. 3.8 pre-SEF).
  • The average duration of SEF placement was 6.4 weeks.
  • Two complications (22%) were noted, related to fixation failure.

Implications:

  • Spanning external fixation is an effective treatment for pediatric open joint burn injuries.
  • Early SEF application is recommended to facilitate soft tissue healing and minimize the number of required skin grafting procedures.
  • This approach offers a viable solution for managing these uncommon and difficult pediatric burn complications.

Related Concept Videos

Burn Injuries01:22

Burn Injuries

Burn injuries occur when the skin and underlying tissues are damaged due to exposure to heat, electricity, chemicals, radiation, or friction. They can vary in severity, from minor superficial burns to severe deep burns that can be life-threatening.
The damage results in the death of skin cells, which can lead to a massive loss of fluid. Dehydration, electrolyte imbalance, and renal and circulatory failure follow, which can be fatal. Burn patients are treated with intravenous fluids to offset...
4.5K
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
266
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
320
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
239
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
305
Structural Joints: Synovial Joints01:16

Structural Joints: Synovial Joints

Synovial joints are the most common type of joint in the body. A key structural characteristic for a synovial joint is the presence of a joint cavity. This fluid-filled space is where the articulating surfaces of the bones contact each other. Also, unlike fibrous or cartilaginous joints, the articulating bone surfaces at a synovial joint are not directly connected to each other with fibrous connective tissue or cartilage. This gives the bones of a synovial joint the ability to move smoothly...
7.1K